Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy

doi:10.5306/wjco.v2.i10.339

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4166)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

393

HTML

3286

Figures (1-2)

259

Tables (1-1)

228

Sum=4166

Oct 10, 2011 (publication date) through Jan 22, 2025

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Clin Oncol. Oct 10, 2011; 2(10): 339-343
Published online Oct 10, 2011. doi: 10.5306/wjco.v2.i10.339

Full Size Figure Download Figure

Figure 1 Kaplan-Meier curves of overall survival. Lentinan+: The group that received chemo-immunotherapy with lentinan (n = 31); Lentinan-: The group that received S-1-based chemotherapy alone (n = 37). OS: Overall survival.

Citation: Ina K, Furuta R, Kataoka T, Kayukawa S, Yoshida T, Miwa T, Yamamura Y, Takeuchi Y. Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy. World J Clin Oncol 2011; 2(10): 339-343
URL: https://www.wjgnet.com/2218-4333/full/v2/i10/339.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i10.339